Please wait



(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)


SCHEDULE 13D/A 0001072613-19-000288 0001666306 XXXXXXXX LIVE 7 Common Stock, $0.0001 par value 02/27/2026 false 0001706431 92764N102 Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158 Mark McDonnell (773) 380-6600 ARCH Venture Management, LLC 8755 W. Higgins Road, Suite 1025 Chicago IL 60631 0001666306 N ARCH Venture Fund IX, L.P. WC N DE 0 12916663 0 12916663 12916663 N 8.1 PN 0001666307 N ARCH Venture Fund IX Overage, L.P. WC N DE 0 12916663 0 12916663 12916663 N 8.1 PN 0001723173 N ARCH Venture Partners IX, L.P. AF N DE 0 12916663 0 12916663 12916663 N 8.1 PN 0001723172 N ARCH Venture Partners IX Overage, L.P. WC N DE 0 12916663 0 12916663 12916663 N 8.1 PN 0001723174 N ARCH Venture Partners IX, LLC AF N DE 0 12916663 0 12916663 12916663 N 8.1 OO 0001219042 N Robert Nelsen AF N X1 584148 12950556 584148 12950556 13534704 N 8.5 IN 0001219039 N Keith Crandell AF N X1 272964 12916663 272964 12916663 13189627 N 8.3 IN 0001219043 N Clinton Bybee AF N X1 30570 12977823 30570 12977823 13008393 N 8.1 IN Common Stock, $0.0001 par value Vir Biotechnology, Inc. 1800 Owens Street, Suite 900 San Francisco CA 94158 This Amendment No. 7 (the "Amendment No. 7") amends the statement on Schedule 13D filed on November 8, 2019 (as amended, the "Original 13D"), relating to the Common Stock, $0.0001 par value per share (the "Common Stock"), of Vir Biotechnology, Inc. (the "Issuer") having its principal executive office at 1800 Owens Street, Suite 900, San Francisco, California 94158. Certain terms used but not defined in this Amendment No. 7 have the meanings assigned thereto in the Original 13D. Items 5(a)-(c) of the Original 13D are hereby amended and supplemented as follows: AVF IX is the record owner of 5,626,008 shares of Common Stock ("AVF IX Record Shares"). AVP IX LP, as the sole general partner of AVF IX, may be deemed to beneficially own the AVF IX Record Shares. AVP IX LLC, as the sole general partner of AVP IX LP, may be deemed to beneficially own the AVF IX Record Shares. AVF IX Overage is the record holder of 7,290,655 shares of Common Stock ("IX Overage Record Shares" and, together with the AVF IX Record Shares, the "Record Shares"). AVP IX Overage GP, as the sole general partner of AVF IX Overage, may be deemed to beneficially own the IX Overage Record Shares. AVP IX LLC, as the sole general partner of AVF IX Overage GP, may be deemed to beneficially own the IX Overage Record Shares. By virtue of their relationship as affiliated entities who have overlapping general partners and managing directors, each entity and Reporting Person may be deemed to share the power to direct the disposition and vote of the Record Shares. In addition, each of the AVP IX Managing Directors may be deemed to share the power to direct the disposition and vote of the Record Shares. Each Reporting Person disclaims beneficial ownership of all securities except for the shares, if any, held of record by such Reporting Person. The percentage of outstanding Common Stock of the Issuer which may be deemed to be beneficially owned by each Reporting Person is set forth on Line 13 of such Reporting Person's cover sheet. Such percentage was calculated based on 159,811,395 outstanding shares of Common Stock, consisting of (i) 139,517,278 shares of Common Stock outstanding as of February 17, 2026, as reported by the Issuer in its Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") on February 23, 2026, and (ii) 20,294,117 shares of Common Stock issued by the Issuer on February 27, 2026, as reported by the Issuer in its Current Report on Form 8-K filed with the SEC on March 2, 2026. In addition, as of February 17, 2026, Crandell is a record holder of 272,964 Shares of Common Stock, Bybee is a record holder of 30,570 shares of Common Stock, and Nelsen is a beneficial owner of 584,148 shares of Common Stock. For Nelsen and Bybee, respectively, 33,893 shares and 61,160 shares of Common Stock held by family trusts are included in Shared Voting and Shared Dispositive figures on cover sheets. Regarding the number of shares as to which such person has: (i) sole power to vote or to direct the vote: See line 7 of cover sheets. (ii) shared power to vote or to direct the vote: See line 8 of cover sheets. (iii) sole power to dispose or to direct the disposition: See line 9 of cover sheets. (iv) shared power to dispose or to direct the disposition: See line 10 of cover sheets. Except as set forth above, none of the Reporting Persons has effected any transaction in the Common Stock during the last 60 days. ARCH Venture Fund IX, L.P. ARCH Venture Partners IX, L.P. its General Partner 03/03/2026 ARCH Venture Partners IX, LLC its General Partner 03/03/2026 /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Keith Crandell, Managing Director 03/03/2026 ARCH Venture Fund IX Overage, L.P. ARCH Venture Partners IX Overage, L.P. its General Partner 03/03/2026 ARCH Venture Partners IX, LLC its General Partner 03/03/2026 /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Keith Crandell, Managing Director 03/03/2026 ARCH Venture Partners IX, L.P. ARCH Venture Partners IX, LLC its General Partner 03/03/2026 /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Keith Crandell, Managing Director 03/03/2026 ARCH Venture Partners IX Overage, L.P. ARCH Venture Partners IX, LLC its General Partner 03/03/2026 /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Keith Crandell, Managing Director 03/03/2026 ARCH Venture Partners IX, LLC /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Keith Crandell, Managing Director 03/03/2026 Robert Nelsen /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Robert Nelsen 03/03/2026 Keith Crandell /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Keith Crandell 03/03/2026 Clinton Bybee /s/ Mark McDonnell Mark McDonnell as Attorney-in-Fact for Clinton Bybee 03/03/2026